Biomarkers of platinum resistance in ovarian cancer: what can we use to improve treatment

B van Zyl, D Tang, NA Bowden - Endocrine-related cancer, 2018 - erc.bioscientifica.com
Ovarian cancer has poor survival rates due to a combination of diagnosis at advanced
disease stages and disease recurrence as a result of platinum chemotherapy resistance …

Epigenetic modifications and head and neck cancer: implications for tumor progression and resistance to therapy

RM Castilho, CH Squarize, LO Almeida - International journal of …, 2017 - mdpi.com
Head and neck squamous carcinoma (HNSCC) is the sixth most prevalent cancer and one
of the most aggressive malignancies worldwide. Despite continuous efforts to identify …

Targeting histone deacetylases in diseases: where are we?

R Benedetti, M Conte, L Altucci - Antioxidants & redox signaling, 2015 - liebertpub.com
Significance: Epigenetic inactivation of pivotal genes involved in cell growth is a hallmark of
human pathologies, in particular cancer. Histone acetylation balance obtained through …

Current insights into oral cancer epigenetics

AI Irimie, C Ciocan, D Gulei, N Mehterov… - International journal of …, 2018 - mdpi.com
Epigenetic modifications have emerged into one of the cancer hallmarks, replacing the
concept of malignant pathologies as being solely genetic-based conditions. The epigenetic …

Epigenetic mechanisms in oral carcinogenesis

JA Gasche, A Goel - Future oncology, 2012 - Taylor & Francis
Dysregulation of gene expression is a frequent occurrence in oral squamous cell carcinoma
(OSCC). However, accumulating evidence suggests that in contrast to genetics, epigenetic …

Epigenetic disregulation in oral cancer

M Mascolo, M Siano, G Ilardi, D Russo… - International journal of …, 2012 - mdpi.com
Squamous cell carcinoma of the oral region (OSCC) is one of the most common and highly
aggressive malignancies worldwide, despite the fact that significant results have been …

Histone deacetylase inhibition in non-small cell lung cancer: hype or hope?

H Mamdani, SI Jalal - Frontiers in cell and developmental biology, 2020 - frontiersin.org
Epigenetic modulation, including acetylation, methylation, phosphorylation, and
ubiquitination, plays a pivotal role in regulation of gene expression. Histone acetylation—a …

Development of histone deacetylase inhibitors for cancer treatment

D Marchion, P Münster - Expert review of anticancer therapy, 2007 - Taylor & Francis
Histone deacetylase (HDAC) inhibitors are an exciting new addition to the arsenal of cancer
therapeutics. The inhibition of HDAC enzymes by HDAC inhibitors shifts the balance …

Entinostat for treatment of solid tumors and hematologic malignancies

J Knipstein, L Gore - Expert opinion on investigational drugs, 2011 - Taylor & Francis
Introduction: A key feature of malignant cells is inappropriate gene suppression resulting in
uncontrolled proliferation, continued cell cycling and a lack of differentiation. Histone …

Combination therapy: histone deacetylase inhibitors and platinum-based chemotherapeutics for cancer

HVK Diyabalanage, ML Granda, JM Hooker - Cancer letters, 2013 - Elsevier
One of the most promising strategies to increase the efficacy of standard chemotherapy
drugs is by combining them with low doses of histone deacetylases inhibitors (HDACis) …